Nalagenetics

Nalagenetics is a biotech company dedicated to reducing adverse drug reactions and increase prescription efficacy through genetic testing.

8 04, 2022

Meningkatnya inovasi biotek untuk mengatasi masalah kesehatan Indonesia

By |2022-06-30T10:36:27+07:00April 8th, 2022|Indonesia, East Ventures, Nusantics, Insights|

Dengan lebih dari 270 juta penduduk, Indonesia adalah pasar medis yang berkembang, didukung oleh lonjakan kesadaran akan perawatan kesehatan di kalangan masyarakat berpenghasilan menengah yang jumlahnya terus meningkat. Namun, Indonesia menghadapi masalah kronis ketika pandemi menunjukan kekurangan dan muncul rasa urgensi yang meningkat untuk mengembangkan sistem dan inovasi perawatan kesehatan yang lebih tangguh.

8 04, 2022

Rising biotech innovations to address Indonesia’s healthcare problems

By |2022-06-30T10:35:19+07:00April 8th, 2022|East Ventures, East Ventures, East Ventures, East Ventures, East Ventures, Nusantics|

With an over 270 million population, Indonesia remains an emerging medical market, supported by the surge of healthcare awareness demanded by the rising middle-income community. However, the country has faced chronic problems as the pandemic unveils shortcomings and an elevated sense of urgency to develop a more resilient healthcare system and innovations.

17 03, 2022

Building the ecosystem of gender equality for the sustainable future

By |2022-06-30T10:35:21+07:00March 17th, 2022|Nalagenetics, Nalagenetics, Nalagenetics, Nalagenetics, Nalagenetics, Nalagenetics, Nalagenetics, Nalagenetics, aruna, Insights, Insights, Insights, From Portfolios|

East Ventures, a pioneering and leading sector-agnostic venture capital firm in Indonesia, has again presented its signature women-centered forum: Women with Impact Forum, as part of the celebration of International Women’s Day on 8 March 2022. This virtual forum discussed “Women as Active Agents for Sustainable Development” with five key speakers from different industries, such as venture capital, tech startups, and social enterprises.

17 03, 2022

Membangun ekosistem kesetaraan gender untuk masa depan yang berkelanjutan

By |2022-06-30T10:36:32+07:00March 17th, 2022|Indonesia, Indonesia, aruna|

East Ventures, perusahaan venture capital (VC) terkemuka dan pionir investasi startup teknologi di seluruh sektor (sector-agnostic) di Indonesia, kembali menghadirkan forum yang berfokus pada pemberdayaan perempuan: Women with Impact Forum, sebagai bagian dari perayaan International Women’s Day / Hari Perempuan Internasional pada tanggal 8 Maret 2022. Forum virtual ini mengangkat topik: “Women as Active Agents for Sustainable Development” yang menghadirkan lima pembicara utama dari berbagai industri, seperti venture capital, startup teknologi, dan perusahaan sosial.

12 10, 2021

East Ventures-backed companies, Nalagenetics and Ruangguru, crowned as Top Startup in the G20 Innovation League 2021

By |2022-06-29T23:35:41+07:00October 12th, 2021|RuangGuru|

Indonesian healthtech company focusing on personalized screening and intervention Nalagenetics and the leading edtech company in Southeast Asia Ruangguru have been chosen as the Top 10 startup in the G20 Innovation League 2021, an international forum held at Sorrento, Italy, on October 9-10, 2021.

12 10, 2021

Portfolio East Ventures di Indonesia, Nalagenetics dan Ruangguru, dinobatkan sebagai Top Startup di G20 Innovation League 2021

By |2022-06-29T23:37:16+07:00October 12th, 2021|RuangGuru|

Perusahaan teknologi medis yang berfokus pada personalisasi skrining dan intervensi Nalagenetics serta perusahaan teknologi pendidikan terbesar di Asia Tenggara Ruangguru dipilih sebagai Top 10 Startup unggul dalam forum internasional G20 Innovation League 2021 yang diselenggarakan di Sorrento, Italia, pada 9-10 Oktober 2021.

Singapore

Marina Bay Financial Centre Tower 3, #31-01A, 12
Marina Boulevard,
Singapore 018982

Indonesia

Jl. Pattimura No.2, RT.1/RW.1, Selong, Kec. Kby. Baru,
Kota Jakarta Selatan,
Daerah Khusus Ibukota Jakarta 12110

Japan

Kohkaido building 2F, 4-2-45, Roppongi Minato-ku, Tokyo 106-0032

© Copyright 2022 East Ventures | All Rights Reserved

Contact us